Pfizer Inc.

PFIZ34.SA·São Paulo
Compare
37.32−0.21 (−0.56%)today
At close: Oct 16, 5:05 PM BRT · May be delayed up to 15 min · BRL

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close37.53
Open0.00
Day range0.0037.32
52-week range0.0037.77
Off day high0.00%
Off 52-week high−1.19%
Volume0.00
Avg. volume (3M)8.46K
Market cap850.85B
EPS (TTM)1.01
Forward P/E—
P/E ratio (TTM)36.95
Dividend yield4.01% (1.50)
Beta (5Y)—
Shares outstanding22.80B
Short interest—
Earnings dateJul 28, 2025
Analyst target—
Profit margin—

Against its peers

Compare in full ›
PFIZ34.SA MRK AZN LLY SNY JNJ.NE
Market cap 850.85B 356.95B 255.80B 1.11T 95.13B 845.20B
P/E (TTM) 37.0 114.8 23.7 41.9 20.9 23.4
Forward P/E — 15.6 14.5 26.4 7.5 —
Price/book 2.0 8.5 5.1 32.8 1.2 0.7
Dividend yield 4.01% 2.33% 1.94% 0.55% 5.96% 2.49%
1-year change +13.09% +69.08% −1.39% +55.39% −18.34% +40.84%
Today −0.56% −0.87% −0.29% −0.79% −2.24% +0.77%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

TipRanks Financial·Negative

Pfizer Shuts One Trial, Bets Big on New Vaccine

TipRanks Pfizer Shuts One Trial, Bets Big on New Vaccine Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer has quietly reshaped parts of its pipeline this week, closing one…

BioTecNika·Positive

Quality Assurance Job at Pfizer | Apply Now

A rare chance has emerged for experienced professionals in Quality Assurance to join Pfizer as a Quality Investigation Approver in Vizag, India. Additionally, this Pfizer QA role is a full-time opportunity for candidates with a strong…

From articles in the 4Search news index.

In the news

224mentions in 30 days
224with it in the headline
Mixedsentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.